NCT04481724View on ClinicalTrials.gov

Gamma-linolenic Acid Supplementation Study

NACompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

February 13, 2023

Study Completion Date

September 15, 2023

Conditions
Weight Trajectory
Interventions
DIETARY_SUPPLEMENT

gamma-linolenic acid

3 capsules per day of GLA for 24 months

DIETARY_SUPPLEMENT

placebo

3 capsules per day of placebo for 24 months

Trial Locations (1)

94105

Virta Health, San Francisco

All Listed Sponsors
lead

Virta Health

INDUSTRY

NCT04481724 - Gamma-linolenic Acid Supplementation Study | Biotech Hunter | Biotech Hunter